Developing a vaccine to treat triple negative breast cancer
Dr Lee-Hwa Tai is developing a personalized immunotherapy vaccine to treat one of the most difficult-to-treat types of breast cancer.
Charity Partner
Canadian Cancer Society
Toronto, Canada
Research Institute
Université de Sherbrooke
Sherbrooke, Quebec, Canada
Researcher
Dr Lee-Hwa Tai
2nd
Breast cancer is the second leading cause of cancer death in Canadian women, with an estimated 5,500 deaths in 2021.
With enough community interest, this project will go live for funding. Join the list of future supporters today.
$544,900
Funding goal when this project goes live for fundraising.